DUBLIN, June 13, 2023 /PRNewswire/ — The “Cell & Gene Therapy Manufacturing Services Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market. cell & gene therapy manufacturing services market.
The global cell & gene therapy manufacturing services market is expected to grow from $5.85 billion in 2022 to $7.25 billion in 2023 at a compound annual growth rate (CAGR) of 23.9%. The cell & gene therapy manufacturing services market is expected to reach $13.50 billion in 2027 at a CAGR of 16.81%.
Major players in the cell & gene therapy manufacturing services market are Thermo fisher scientific inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara bio inc., Nikon corporation, Fujifilm Holdings Corporation, F. Hoffmann-la roche ltd., Oxford Biomedica, CGT Catapult, Bluebird bio, Inc., Boehringer Ingelheim International GmbH, and Innovative Cellular Therapeutics Co. Ltd.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the COVID-19 and how it is likely to emerge and grow as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.
The main types of cell and gene therapy manufacturing services include gene therapy and cell therapy. Gene therapy is a medical strategy that addresses the underlying genetic issue in order to treat or prevent disease. They are used for commercial manufacturing and clinical manufacturing applications for various indications including central nervous system disorders, ophthalmology diseases, cardiovascular diseases, infectious diseases, orthopaedic diseases and oncology diseases. These services are used by academic and research institutes, pharmaceutical and biotechnology companies, and others.
Technological advancements are a key trend gaining popularity in the cell and gene therapy manufacturing services market. Major companies operating in the cell and gene therapy manufacturing services market are adopting new technologies to sustain their position in the market.
For instance, in October 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company specializing in various preclinical and clinical laboratory, gene therapy, and cell therapy services, launched the navigationT Vector Platform (navigation). It is a platform that simplifies the path to GMP Adeno-Associated Virus (AAV) vector manufacturing without requiring extensive process development.
Compared to standard manufacturing workflows, the navigation platform can cut a program’s timeframe to GMP by 55% for viral vector gene therapy researchers. Charles River’s navigation technique is based on a unique high-productivity HEK293 suspension cell line that can be scaled up and serotyped to meet clients’ needs.
North America was the largest region in the cell and gene therapy manufacturing services market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell & gene therapy manufacturing services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell & gene therapy manufacturing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The high incidence of cancer and other target diseases is expected to propel the growth of the cell and gene therapy manufacturing services market going forward. Cancer is a severe disorder in which the body’s cells reproduce fast and uncontrollably, resulting in abnormal growth. Cell and gene therapies are developing as promising new strategies to combat the rising incidence of cancer, which is driving the demand for novel and efficient treatment choices.
The cell and gene therapy manufacturing services market includes revenues earned by cell and gene therapy manufacturing and related services which include analytical and process development, current good manufacturing practice cell therapy manufacturing services of autologous and allogeneic t-cells, natural killer cells, dendritic cells, mesenchymal stem cells, hematopoietic stem cells, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Key Topics Covered:
1. Executive Summary
2. Cell & Gene Therapy Manufacturing Services Market Characteristics
3. Cell & Gene Therapy Manufacturing Services Market Trends And Strategies
4. Cell & Gene Therapy Manufacturing Services Market – Macro Economic Scenario
4.1. COVID-19 Impact On Cell & Gene Therapy Manufacturing Services Market
4.2. Ukraine-Russia War Impact On Cell & Gene Therapy Manufacturing Services Market
4.3. Impact Of High Inflation On Cell & Gene Therapy Manufacturing Services Market
5. Cell & Gene Therapy Manufacturing Services Market Size And Growth
5.1. Global Cell & Gene Therapy Manufacturing Services Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Cell & Gene Therapy Manufacturing Services Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Cell & Gene Therapy Manufacturing Services Market Segmentation
6.1. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Gene Therapy
- Cell Therapy
6.2. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Central Nervous System Disorders
- Ophthalmology Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Orthopaedic Diseases
- Oncology Diseases
6.3. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Commercial Manufacturing
- Clinical Manufacturing
6.4. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Academic And Research Institutes
- Pharmaceutical And Biotechnology Companies
- Other End-Users
7. Cell & Gene Therapy Manufacturing Services Market Regional And Country Analysis
7.1. Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/h3u3vk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
